These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6413960)

  • 1. Diabetic ketoacidosis associated with outpatient treatment using continuous subcutaneous insulin infusion.
    Boulton AJ; Knight G; Drury J; Ward JD
    Postgrad Med J; 1983 Jul; 59(693):438-9. PubMed ID: 6413960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatalities Due to Failure of Continuous Subcutaneous Insulin Infusion Devices: A Report of Six Cases.
    Ziegler A; Williams T; Yarid N; Schultz DL; Bundock EA
    J Forensic Sci; 2019 Jan; 64(1):275-280. PubMed ID: 29940703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA; Jørgensen UL; Gjessing HJ
    J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetic ketoacidosis during insulin pump therapy].
    Walter H; Günther A; Timmler R; Mehnert H
    Dtsch Med Wochenschr; 1989 May; 114(18):706-8. PubMed ID: 2496965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to discontinuation of continuous subcutaneous insulin-infusion therapy.
    Guinn TS; Bailey GJ; Mecklenburg RS
    Diabetes Care; 1988 Jan; 11(1):46-51. PubMed ID: 3123187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetics treated with continuous subcutaneous insulin infusion pumps.
    Foley-Nolan D; Foley-Nolan A; Temperley D; Devlin J
    Ir Med J; 1989 Dec; 82(4):159-60. PubMed ID: 2516015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion.
    Peden NR; Braaten JT; McKendry JB
    Diabetes Care; 1984; 7(1):1-5. PubMed ID: 6423352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data.
    Kjærulff MLBG; Astrup BS
    J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and Relevance of Insulin Pump Therapy in the Aetiology of Ketoacidosis in People with Type 1 Diabetes.
    Giessmann LC; Kann PH
    Exp Clin Endocrinol Diabetes; 2020 Nov; 128(11):745-751. PubMed ID: 30049002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Modality-Dependent Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes: Danish Adult Diabetes Database Study.
    Hoshina S; Andersen GS; Jørgensen ME; Ridderstråle M; Vistisen D; Andersen HU
    Diabetes Technol Ther; 2018 Mar; 20(3):229-234. PubMed ID: 29437465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ketoacidosis in long-term therapy with insulin pumps. Incidence, causes, circumstances].
    Walter H; Günther A; Timmler R; Mehnert H
    Med Klin (Munich); 1989 Dec; 84(12):565-8. PubMed ID: 2516236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic ketoacidosis in pregnancy resulting from insulin pump failure. A case report.
    Lindenbaum C; Menzin A; Ludmir J
    J Reprod Med; 1993 Apr; 38(4):306-8. PubMed ID: 8501740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with insulin pump during hospital care should be questioned. Three cases illustrate the risk of ketoacidosis].
    Gubrianska D; Moberg E; Palmér M
    Lakartidningen; 2009 Aug 5-18; 106(32-33):1967-8. PubMed ID: 19764373
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic ketoacidosis caused by exposure of insulin pump to heat and sunlight.
    Pryce R
    BMJ; 2009 Jan; 338():a2218. PubMed ID: 19124546
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy.
    Lauritzen T
    Dan Med Bull; 1985 May; 32(2):104-18. PubMed ID: 3924487
    [No Abstract]   [Full Text] [Related]  

  • 16. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of ketosis during intensive insulin therapy in pre-school-age diabetic children.
    Brambilla P; Artavia-Loria E; Chaussain JL; Bougneres PF
    Diabetes Care; 1987; 10(1):44-8. PubMed ID: 3105985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute mishaps during insulin pump treatment.
    Lancet; 1985 Apr; 1(8434):911-2. PubMed ID: 2858751
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ketoacidosis during ambulatory treatment by continuous subcutaneous infusion of insulin. Possible role of catheter infection].
    Leguerrier AM; Allannic H; Lorcy Y
    Presse Med; 1984 Apr; 13(16):1008. PubMed ID: 6232520
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient-reported experience with Velosulin human insulin in continuous subcutaneous insulin infusion.
    Marcus A; Bode B; Drexler A; Etkind E; Koch MM; Liljenquist JE; McCulloch DK; Strowig SM; Tanenberg RJ
    Clin Ther; 1995; 17(2):204-13. PubMed ID: 7614521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.